Skip to content
Screener

Eve Holding EVEX Evtol — Research And Development Expense

Other segment segments

Service Support
$2.55M+91.1%
Uatm
$489K-48.7%

Similar metrics at other companies

Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%
Helios Technologies logo
HLIOUnallocated Expenses — Research And Development Expense
$0
Dianthus Therapeutics logo
DNTHDiscovery Expenses — Research And Development Expense
$1.36M+51.4%
Innoviva, Inc. logo
INVAInternal Expenses — Research And Development Expense
$2.73M+127%

Other financials

Income statement

See full
Operating income-$66.3M-26.1%
Net income-$68.8M-41.1%
EPS (diluted)-$0.14-16.7%

Balance sheet

See full
Cash & equivalents$47.9M+11.5%
Total debt$299.2M+110%
Total equity$56.1M-26.4%
Total assets$484.3M+59.2%

Cash flow

See full
Operating cash flow-$68.1M-174%
CapEx$526.0K+13.4%
Free cash flow-$68.6M-171%

Valuation

See full
Market cap$961.82M-45.2%
Enterprise value$1.21B-35.3%

Returns & leverage

See full
Return on equity-369.6%-1,138pp
Debt / equity5.3×+3.5×
Current ratio3.8×+0.2×

Where this comes from

Reported directly by Eve Holding in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Eve Holding’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 6:02 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001554855-26-000876
Research and development expensesThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
eVTOL$$56,03942,423
Service and Operations Solutions2,5491,334
UATM489953
Total segment expenses$$59,07744,711
Total segment loss(59,077)(44,711)
Expenses (income) not allocated to segments, net (a)9,6424,631
Loss before income taxes$$(68,718)(49,342)

Document

FAQ

What is Eve Holding's evtol — research and development expense?
Eve Holding (EVEX) reported evtol — research and development expense of $56.04M in Q1 2026.
How has Eve Holding's evtol — research and development expense changed year-over-year?
Eve Holding's evtol — research and development expense increased by 32.1% year-over-year, from $42.42M to $56.04M.
What is the long-term trend for Eve Holding's evtol — research and development expense?
Over 4 years (2021 to 2025), Eve Holding's evtol — research and development expense has grown at a 101.5% compound annual growth rate (CAGR), from $11.21M to $184.89M.
What does evtol — research and development expense mean?
This metric represents the total costs incurred by the eVTOL business segment for the design, engineering, and development of electric vertical take-off and landing aircraft. It captures investments in prototyping, testing, and technological innovation required to bring advanced air mobility vehicles to commercial certification and market readiness. Monitoring this expense provides insight into the company's commitment to product innovation and the pace of its capital-intensive development lifecycle.

Ask your AI about Eve Holding's evtol — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude